EUVIMED · CrossrefJournal
Expert Review of Clinical Pharmacology
ISSN 1751-2433 · Informa UK Limited
Latest articles
Incremental associations of pharmacological components in heart failure with mildly reduced or preserved ejection fraction: a systematic review and component network meta-analysis
Optimizing the management of obstructive sleep apnea with pharmacotherapy
Repetitive transcranial magnetic stimulation with concomitant pharmacotherapy for addictive disorders: a review of current evidence
Refining antibiotic dosing regimens for the treatment of sepsis in critically ill patients in the intensive care unit
TRPM8 channel blockers as a potential new pharmacological class for the treatment of migraine
Selective IL-23p19 blockade in moderate-to-severe Crohn’s disease: the role and limitations of risankizumab in complex populations
From metabolic therapy to addiction care: a clinical pharmacology roadmap for GLP-1 receptor agonists in substance use disorders
Pharmacotherapy and behavioral treatment for substance use disorders during pregnancy and postpartum: a narrative review
Genetic determinants of direct oral anticoagulant (DOAC) response: evidence, limitations and barriers to clinical implementation
Mathematical modeling in mRNA therapeutics: toward a pathway to individualized treatment protocols
The roles of ROCK1 and ROCK2 in cardiopulmonary and fibrotic disease: considerations for pan-ROCK inhibition as a therapeutic approach
Evaluating current and emerging pharmacological treatment options for men with androgenetic alopecia
Rethinking endpoints for anti-obesity pharmacotherapy in patients with HR+ early breast cancer receiving endocrine therapy: from body weight and BMI to body composition
Dupilumab versus upadacitinib in atopic dermatitis: comparative effectiveness, response kinetics, and treatment persistence
Could obinutuzumab be the new therapy for adults with primary membranous nephropathy?
Therapeutic utility of clinical and laboratory markers in chronic spontaneous urticaria – a narrative review
Modern antidiabetic therapy in older adults with type 2 diabetes: evidence, best practice and a clinical pharmacist’s framework
Dupilumab and alopecia areata: direct effect, indirect effect, or endotype-specific response?
Clinical trial evidence for disease-modifying therapies across the type 1 diabetes continuum: from presymptomatic stages to recent-onset disease
Could GLP-1RAs improve outcomes for patients with chronic migraine?
Tirzepatide in type 1 diabetes: beyond mere weight loss
Understanding the relationship between aripiprazole levels in the blood and recurrence of mood episodes in people diagnosed with bipolar I disorder treated with a once-monthly injection of aripiprazole monohydrate: a plain language summary
Brexpiprazole for anxiety symptoms in people living with schizophrenia: a plain language summary
Beyond snapshot dosing: a dynamic living digital twin framework for model-informed precision dosing in critical illness
The systems medicine view of semaglutide: from clinical trials to molecular mechanisms
Obese and overweight patients with type 2 diabetes mellitus are not treated optimally - an overview of current clinical practice and future perspectives
Factors to consider when designing clinical trials for repurposed drugs
Complement C5 inhibitor crovalimab for the treatment of paroxysmal nocturnal hemoglobinuria
Treatment strategies for pulmonary arterial hypertension associated with adult congenital heart diseases
Is dose adjustment of dolutegravir necessary in Chinese adults living with HIV across different body weight levels? A population pharmacokinetics analysis
EUVIMED